Roche shares rose sharply after the company reported a clinical trial success that could help cushion it against looming competition for Herceptin and boost sales for its newer Perjeta drug.
from WSJ.com: US Business http://ift.tt/2mcqnW8
via IFTTT
No comments:
Post a Comment